Evaluation of the Allergenicity of AMPHADASE INJECTION (Hyaluronidase Injection USP)
Public ClinicalTrials.gov record NCT01689363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blinded, Negative- and Positive-Controlled Study for Evaluation of the Allergenicity of Amphadase® in Healthy Volunteers Using Intradermal Skin Test
Study identification
- NCT ID
- NCT01689363
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Amphastar Pharmaceuticals, Inc.
- Industry
- Enrollment
- 253 participants
Conditions and interventions
Conditions
Interventions
- Hyaluronidase Drug
- Histamine Drug
- Saline Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2012
- Primary completion
- Oct 31, 2012
- Completion
- Nov 30, 2012
- Last update posted
- Jan 19, 2017
2012
United States locations
- U.S. sites
- 5
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Amphastar Site 0022 | Eugene | Oregon | 97401 | — |
| Amphastar Site 0023 | Lake Oswego | Oregon | 97035 | — |
| Amphastar Site 0026 | Portland | Oregon | 97202 | — |
| Amphastar Site 0038 | Renton | Washington | 98057 | — |
| Amphastar Site 0034 | Seattle | Washington | 98115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01689363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01689363 live on ClinicalTrials.gov.